Can't wait to see the results. Efficacy across several patients would be amazing but happy as long as no signs of dose limiting toxicities are present.
Also, not sure if its a typo or when the plan was changed (probably an older figure), on Chimerics website under pipeline, the CHM 1101 dosing schema states 220 x 10^6 as the third dose, rather than 240 x 10^6 described here and in the annual report.
Anyone have any idea when they increased the dosage of the third cohort or if its just a type?
Ann: Dosing complete in 3rd cohort of CHM 1101 (CLTX CAR T) trial, page-5
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
